211 related articles for article (PubMed ID: 36529291)
1. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
[TBL] [Abstract][Full Text] [Related]
2. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.
Kaasbøll OJ; Gadicherla AK; Wang JH; Monsen VT; Hagelin EMV; Dong MQ; Attramadal H
J Biol Chem; 2018 Nov; 293(46):17953-17970. PubMed ID: 30262666
[TBL] [Abstract][Full Text] [Related]
4. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
[TBL] [Abstract][Full Text] [Related]
5. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
6. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
[TBL] [Abstract][Full Text] [Related]
7. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
[TBL] [Abstract][Full Text] [Related]
8. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
9. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into regulation of CCN protein activities and functions.
Monsen VT; Attramadal H
J Cell Commun Signal; 2023 Jun; 17(2):371-390. PubMed ID: 37245184
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and transcriptional regulation of CCN5 in the heart after myocardial infarction.
Zolfaghari S; Kaasbøll OJ; Ahmed MS; Line FA; Hagelin EMV; Monsen VT; Attramadal H
J Cell Commun Signal; 2022 Sep; 16(3):377-395. PubMed ID: 34854055
[TBL] [Abstract][Full Text] [Related]
12. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism].
Zhang CY; Xie X; Gao DS; Zhang CX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815
[TBL] [Abstract][Full Text] [Related]
13. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
14. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
[TBL] [Abstract][Full Text] [Related]
15. Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis.
MacDonald IJ; Huang CC; Liu SC; Lin YY; Tang CH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919365
[TBL] [Abstract][Full Text] [Related]
16. Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2010 Oct; 4(3):155-6. PubMed ID: 21063505
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).
Li J; Ye L; Owen S; Weeks HP; Zhang Z; Jiang WG
Int J Mol Med; 2015 Dec; 36(6):1451-63. PubMed ID: 26498181
[TBL] [Abstract][Full Text] [Related]
18. Expression and biological function of the cellular communication network factor 5 (CCN5) in primary liver cells.
Borkham-Kamphorst E; Meurer SK; Weiskirchen R
J Cell Commun Signal; 2023 Jun; 17(2):307-320. PubMed ID: 37166689
[TBL] [Abstract][Full Text] [Related]
19. Investigating microenvironmental regulation of human chordoma cell behaviour.
Patel P; Brooks C; Seneviratne A; Hess DA; Séguin CA
PLoS One; 2014; 9(12):e115909. PubMed ID: 25541962
[TBL] [Abstract][Full Text] [Related]
20. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.
Zuo GW; Kohls CD; He BC; Chen L; Zhang W; Shi Q; Zhang BQ; Kang Q; Luo J; Luo X; Wagner ER; Kim SH; Restegar F; Haydon RC; Deng ZL; Luu HH; He TC; Luo Q
Histol Histopathol; 2010 Jun; 25(6):795-806. PubMed ID: 20376786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
